|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Pulmatrix Pulls in $5.7M DARPA Grant to Develop Drug Against Respiratory Threats
|
Ryan McBride |
12/14/10 |
Boston
|
|
Semprus Scores $18M More to Help Improve Medical Devices
|
Gregory T. Huang |
12/13/10 |
Boston
|
|
EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News
|
Rebecca Zacks |
11/18/10 |
Boston
|
|
$3M for Kala Pharmaceuticals
|
Ryan McBride |
11/12/10 |
Boston
|
|
InVivo Completes Reverse Merger, Raising $10.5M
|
Ryan McBride |
10/27/10 |
Boston
|
|
Former Solvay Pharma Chief Takes Lead Role at Startup Selecta Biosciences
|
Ryan McBride |
08/16/10 |
Boston
|
|
In-Q-Tel, the CIA’s Investment Arm, Quietly Backing Seventh Sense Biosystems
|
Ryan McBride |
08/05/10 |
Boston
|
|
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round
|
Ryan McBride |
06/29/10 |
Boston
|
|
Logical and Arsenal Get $10M Apiece, Constant Contact Acquires NutshellMail, Avila Gets $209M From Clovis, & More Boston-Area Deals News
|
Erin Kutz |
05/26/10 |
Boston
|
|
Vertex Awaits Results of Hepatitis C Drug Trial, Helicos and Pfizer Cut Jobs, St. Jude Acquires LightLab, & More Boston-Area Life Sciences News
|
Erin Kutz |
05/21/10 |
Boston
|
|
Seventh Sense, Rox Anderson and Bob Langer Startup, Seeks to Collect Blood With No Pain
|
Ryan McBride |
05/20/10 |
Boston
|
|
Arsenal Medical, Startup Linked to Langer and Whitesides, Adds $10M
|
Ryan McBride |
05/19/10 |
Boston
|
|
Selecta Biosciences, a Bob Langer Creation, Raises $15M For Nanoparticle Vaccines
|
Luke Timmerman |
04/05/10 |
Boston
|
|
Bonding with BIND Biosciences’s New CEO Scott Minick
|
Ryan McBride |
01/15/10 |
Boston
|
|
The Boston Deals You Missed During the Holidays: Cash for Kala Pharma, Funds for ViewFinity, Silver for SCVNGR, & More
|
Ryan McBride |
01/04/10 |
Boston
|
|
Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M
|
Luke Timmerman |
12/23/09 |
Boston
|
|
Millipore Taps Langer for Board Seat
|
Ryan McBride |
12/16/09 |
Boston
|
|
Taris Biomedical, MIT Spinoff With Bladder Drug Device, Leaps Ahead To Mid-Stage Trial
|
Luke Timmerman |
12/02/09 |
Boston
|
|
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs
|
Luke Timmerman |
11/02/09 |
Boston
|
|
The Kauffman Foundation: Bringing Entrepreneurship Up to Date in Kansas City
|
Wade Roush |
10/16/09 |
National
|
|
MIT Plans New Online Publication About Entrepreneurship
|
Ryan McBride |
10/08/09 |
Boston
|
|
A123 Plans $200M+ IPO, Seaside Sees $30M, Verivue Grabs $20.1M, & More Boston-Area Deals News
|
Rebecca Zacks |
09/18/09 |
Boston
|
|
Living Proof Lathers $9M in Fresh Capital into Beauty Products Operation
|
Ryan McBride |
06/19/09 |
Boston
|
|
Flagship Ventures Taps Carbeck to Work on Hush-Hush Startup Project
|
Ryan McBride |
06/15/09 |
Boston
|
|
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/10/09 |
Boston
|
|
Taris Biomedical Gives Glimpse of Drug-Delivery Tech, Discloses $15M Series A
|
Ryan McBride |
06/09/09 |
Boston
|
|
Seventh Sense Biosystems Developing Tech Akin to Check-Engine Light for the Body
|
Ryan McBride |
06/05/09 |
Boston
|
|
Arsenal Medical CTO Jeff Carbeck on His Secretive Startup, Attractions of Clean Energy Sector
|
Ryan McBride |
05/14/09 |
Boston
|
|
Fresh Capital Flows to Arsenal, Azuki, Synageva, and Viximo
|
Ryan McBride |
05/05/09 |
Boston
|
|
Polaris’s McGuire Takes Helm at U.S. Venture Group, Plans to Fight Obama Effort to Hike Taxes on VC Firms
|
Ryan McBride |
05/01/09 |
Boston
|
|
Page 2 of
3 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.